Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Anti-androgens might help reduce COVID-19 severity in men.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Early diagnosis and coordinated care are crucial for managing lupus effectively.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Testosterone may influence COVID-19 severity and outcomes.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Old age, male sex, smoking, and obesity may affect COVID-19 severity, but more research is needed.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

iPSCs are promising for studying and treating COVID-19.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

The I National Academic Congress of Dermatology in 2021 expanded to include participants from across Brazil and discussed dermatology topics, including COVID-19.

Drug repositioning can save time and money but needs more support.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Genetic differences affect how people respond to COVID-19.

COVID-19 can cause hair loss and nail changes in some patients.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.